Login / Signup
CPL-01, an investigational long-acting ropivacaine, demonstrates safety and efficacy in open inguinal hernia repair.
H T Xu
J Zimmerman
T Bertoch
L Chen
P J Chen
E Onel
Published in:
Hernia : the journal of hernias and abdominal wall surgery (2024)
Results suggest that CPL-01 may be the first long-acting ropivacaine to address postoperative pain while reducing the need for opioids.
Keyphrases
</>
postoperative pain
chronic pain
minimally invasive
pain management
phase ii
clinical trial
randomized controlled trial